# A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis

> **NCT01857479** · PHASE2,PHASE3 · COMPLETED · sponsor: **Post Graduate Institute of Medical Education and Research, Chandigarh** · enrollment: 21 (actual)

## Conditions studied

- Allergic Bronchopulmonary Aspergillosis

## Interventions

- **DRUG:** Inhaled budesonide
- **DRUG:** Inhaled amphotericin

## Key facts

- **NCT ID:** NCT01857479
- **Lead sponsor:** Post Graduate Institute of Medical Education and Research, Chandigarh
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2015-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857479, "A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01857479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*